Polygenic Risk Scores: Improving the Prediction of Future Disease or Added Complexity?
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Alireza Z, Maleeha M, Kaikkonen M, Fortino V J Transl Med. 2024; 22(1):356.
PMID: 38627847 PMC: 11020205. DOI: 10.1186/s12967-024-05090-1.
References
1.
Domingue B, Trejo S, Armstrong-Carter E, Tucker-Drob E
. Interactions between Polygenic Scores and Environments: Methodological and Conceptual Challenges. Sociol Sci. 2022; 7:465-486.
PMC: 9455807.
DOI: 10.15195/v7.a19.
View
2.
Damask A, Steg P, Schwartz G, Szarek M, Hagstrom E, Badimon L
. Patients With High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit From Alirocumab Treatment in the ODYSSEY OUTCOMES Trial. Circulation. 2019; 141(8):624-636.
DOI: 10.1161/CIRCULATIONAHA.119.044434.
View
3.
Finnikin S, Ryan R, Marshall T
. Statin initiations and QRISK2 scoring in UK general practice: a THIN database study. Br J Gen Pract. 2017; 67(665):e881-e887.
PMC: 5697558.
DOI: 10.3399/bjgp17X693485.
View
4.
Mosley J, Gupta D, Tan J, Yao J, Wells Q, Shaffer C
. Predictive Accuracy of a Polygenic Risk Score Compared With a Clinical Risk Score for Incident Coronary Heart Disease. JAMA. 2020; 323(7):627-635.
PMC: 7042849.
DOI: 10.1001/jama.2019.21782.
View
5.
. Responsible use of polygenic risk scores in the clinic: potential benefits, risks and gaps. Nat Med. 2021; 27(11):1876-1884.
DOI: 10.1038/s41591-021-01549-6.
View